NHS · Insider Trading

Neuberger High Yield Strategies Fund Inc.

Iron condor setups Expected move IV rank history Fibonacci levels Insider trading

Every open-market purchase and sale reported by NHS officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.

Form 4 Filings

most recent

Open-Market Buys

code P

Sales

code S

Reporting Insiders

current holders

NHS — Recent Form 4 Transactions (latest 2026-09-01)

Filed	Insider	Role	Type	Shares	Value
2026-09-01	BANK OF AMERICA NA	10%+ Owner	J	+200	—
2026-04-27	Chris Kocinski	—	X	+7,000	+$45.50K
2026-04-24	Joseph Lind	—	X	+12,833	+$83.41K
2025-07-21	Chris Kocinski	—	Buy	+6,000	+$44.40K
2025-05-30	Chris Kocinski	—	Buy	+15,000	+$111.60K
2023-09-20	MetLife Investment Management, LLC	10%+ Owner	J	−52,080,000	—
2023-07-05	Joseph Lind	—	X	+5,833	+$43.28K
2023-07-05	Bradley Tank	—	X	+119,648	+$887.79K
2023-06-23	George W Morriss	Director	X	+3,422	+$25.39K
2023-06-23	Joseph Lind	—	X	+6,667	+$49.47K
2023-06-23	Bradley Tank	—	X	+59,824	+$443.89K
2022-06-10	MetLife Investment Management, LLC	10%+ Owner	MIXED	−52,401,400	−$1264.88T
2022-06-10	MetLife Investment Management, LLC	10%+ Owner	J	−12,020,000	−$53.00T
2022-06-08	Joseph Lind	—	Buy	+10,000	+$91.95K
2022-06-07	MetLife Investment Management, LLC	10%+ Owner	Buy	+26,500,000	+$702.25T
2022-05-19	Bradley Tank	—	X	+44,866	+$385.85K
2022-05-19	George W Morriss	Director	X	+3,763	+$32.36K
2022-05-19	Joseph Lind	—	X	+5,000	+$43.00K
2020-12-16	Saba Capital Management, L.P.	10%+ Owner	D	−7,144,166	−$85.94M
2020-12-14	Saba Capital Management, L.P.	10%+ Owner	Sell	−200,000	−$2.37M
2020-05-28	Boaz Weinstein	10%+ Owner	Buy	+82,326	+$858.33K
2020-05-26	Saba Capital Management, L.P.	10%+ Owner	Buy	+34,610	+$347.26K
2020-05-21	Saba Capital Management, L.P.	10%+ Owner	Buy	+150,572	+$1.51M
2020-05-19	Boaz Weinstein	10%+ Owner	Buy	+87,372	+$859.35K
2020-05-15	Saba Capital Management, L.P.	10%+ Owner	Buy	+161,022	+$1.58M
2020-05-13	Boaz Weinstein	10%+ Owner	Buy	+40,076	+$398.86K
2020-05-11	Boaz Weinstein	10%+ Owner	Buy	+309,960	+$3.08M
2020-05-07	Saba Capital Management, L.P.	10%+ Owner	Buy	+20,000	+$196.00K
2020-05-05	Boaz Weinstein	10%+ Owner	Buy	+41,952	+$403.16K
2020-04-29	Saba Capital Management, L.P.	10%+ Owner	Buy	+42,952	+$402.40K
2020-04-20	Saba Capital Management, L.P.	10%+ Owner	Buy	+33,996	+$323.64K
2020-04-16	Saba Capital Management, L.P.	10%+ Owner	Buy	+86	+$826
2020-04-06	Boaz Weinstein	10%+ Owner	Buy	+137,920	+$1.17M
2020-04-02	Boaz Weinstein	10%+ Owner	Buy	+56,714	+$485.57K
2020-03-31	Saba Capital Management, L.P.	10%+ Owner	Buy	+28,998	+$246.77K
2020-03-27	Saba Capital Management, L.P.	10%+ Owner	Buy	+1,438	+$11.10K
2020-03-25	Saba Capital Management, L.P.	10%+ Owner	Buy	+10,704	+$78.18K
2020-03-23	Boaz Weinstein	10%+ Owner	Buy	+206,136	+$1.69M
2020-03-18	Boaz Weinstein	10%+ Owner	Buy	+61,186	+$555.86K
2020-03-16	Boaz Weinstein	10%+ Owner	Buy	+138,860	+$1.33M
2020-03-11	Boaz Weinstein	10%+ Owner	Buy	+30,356	+$328.76K
2020-03-06	Saba Capital Management, L.P.	10%+ Owner	Buy	+260,224	+$3.10M
2020-03-04	Saba Capital Management, L.P.	10%+ Owner	Buy	+278,438	+$3.27M
2019-04-12	Saba Capital Management, L.P.	10%+ Owner	Buy	+243,500	+$2.83M
2019-04-10	Boaz Weinstein	10%+ Owner	Buy	+265,272	+$3.06M
2019-04-08	Boaz Weinstein	10%+ Owner	Buy	+189,290	+$2.18M
2019-04-03	Saba Capital Management, L.P.	10%+ Owner	Buy	+19,240	+$218.76K
2019-04-01	Boaz Weinstein	10%+ Owner	Buy	+36,596	+$413.82K
2019-03-28	Saba Capital Management, L.P.	10%+ Owner	Buy	+23,538	+$265.57K
2019-03-25	Boaz Weinstein	10%+ Owner	Buy	+38,958	+$441.70K

NHS — Current Insider Holders

Insider	Role	Shares Held	Value
Joseph Lind	—	45,333	$242.08K
Chris Kocinski	—	28,000	$149.52K
BANK OF AMERICA NA	10%+ Owner	500	$2.67K

NHS Insider Trading FAQ

Who are the insiders at NHS?

3 officers, directors and 10%+ beneficial owners currently report holdings in NHS via SEC Form 4.

Are NHS insiders buying or selling?

Across the 50 most recent Form 4 filings for NHS, 34 were open-market purchases (code P) and 1 were sales (code S). Sales frequently reflect scheduled 10b5-1 plans or tax withholding rather than a view on the stock.

How current is NHS insider data?

Form 4 must be filed within two business days of the transaction, so this is close to real time. The most recent NHS filing is dated 2026-09-01.

How to read Form 4 activity

Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.

Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.

Full filing history and per-insider positions are on the NHS quote page; the site-wide leaderboard is on the insider transactions hub.